Shine-On BioMedical Co.,Ltd. (TPEX:6926)
Taiwan · Delayed Price · Currency is TWD 63.40
-0.10 (-0.16%)
Aug 19, 2026, 9:58 AM CST
Shine-On BioMedical Revenue
Shine-On BioMedical had revenue of 30.00M TWD in the half year ending December 31, 2025, with 214.99% growth. This brings the company's revenue in the last twelve months to 50.62M. In the year 2025, Shine-On BioMedical had annual revenue of 30.00M.
Revenue (ttm)
50.62M
Revenue Growth
n/a
P/S Ratio
62.48
Revenue / Employee
n/a
Employees
22
Market Cap
3.16B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 30.00M | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 9.52M | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Apex Biotechnology | 1.87B |
| SYN-TECH Chem. & Pharm. | 1.27B |
| Sagittarius Life Science | 392.26M |
| BioGend Therapeutics | 236.58M |
| 3D Global Biotech | 159.19M |
| Formosa Pharmaceuticals | 52.59M |
| OBI Pharma | 49.68M |
| Intech Biopharm | 48.55M |